Reductions of the components of the calreticulin/calnexin quality‐control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-4547|92|10|1319-1329

ISSN： 0360-4012

Source： JOURNAL OF NEUROSCIENCE RESEARCH, Vol.92, Iss.10, 2014-10, pp. : 1319-1329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is the ubiquitin-proteasome system impaired in Huntington’s disease?

By Ortega Z.   Díaz-Hernández M.   Lucas J.  

Cellular and Molecular Life Sciences CMLS, Vol. 64, Iss. 17, 2007-09 ,pp. : 2245-2257

Springer Publishing Company

Access to resources Recommend Favorite

Dual target strategy: combining distinct non‐dopaminergic treatments reduces neuronal cell loss and synergistically modulates l‐DOPA‐induced rotational behavior in a rodent model of Parkinson's disease

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 134, Iss. 4, 2015-08 ,pp. : 740-747

John Wiley & Sons Inc

Access to resources Recommend Favorite

Protein translocation without specific quality control in a computational model of the Tat system

By Nayak Chitra R   Brown Aidan I   Rutenberg Andrew D  

Physical Biology, Vol. 11, Iss. 5, 2014-10 ,pp. : 56005-56013

IOP Publishing

Access to resources Recommend Favorite

1‐[2‐(4‐Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease

By  

JOURNAL OF NEUROSCIENCE RESEARCH, Vol. 93, Iss. 8, 2015-08 ,pp. : 1267-1278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ubiquitin-proteasome system

By Wolf D.  

Cellular and Molecular Life Sciences CMLS, Vol. 61, Iss. 13, 2004-06 ,pp. : 1601-1614

Springer Publishing Company

Access to resources Recommend Favorite